z-logo
open-access-imgOpen Access
Salmonella typhi vaccination response study reveals defective antibody production selective IgA deficiency patient
Author(s) -
Daniel Pleguezuelo,
Carla Gianelli
Publication year - 2015
Language(s) - English
Resource type - Journals
ISSN - 2448-9190
DOI - 10.29262/ram.v62i4.84
Subject(s) - medicine , common variable immunodeficiency , vaccination , toxoid , immunology , tetanus , selective iga deficiency , streptococcus pneumoniae , salmonella typhi , immunodeficiency , antibody , microbiology and biotechnology , immune system , antibiotics , biology , escherichia coli , biochemistry , gene
Selective IgA deficiency (SIgAD) is the most prevalent immunodeficiency worldwide, progressing to common variable immunodeficiency only in few reported cases. We report the case of a Spanish female aged 22 and diagnosed of selective IgA deficiency, a long history of bronchitis, several episodes of pneumonia, bilateral bronchiectasis, normal IgG, IgM, IgG subclasses, and detectable pre-vaccination IgG antibodies against tetanus toxoid and Streptococcus pneumoniae. She was evaluated in our clinic in order to rule out common variable immunodeficiency. We observed good antibody response to tetanus toxoid, absence of circulating switched memory B cells, decreased response to pneumococcal polysaccharide antigens and a lack of response to Salmonella typhi vaccine. Most SIgAD patients presents with upper respiratory tract infections or mild diarrhea. Those with lower tract infections, pneumonia or untreatable diarrhea should follow B-cell subpopulations’ study and antibody response to vaccines. Absence of response to Salmonella typhi vaccine allowed us to expose the defective antibody production.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here